Heor | Pharma & Vendor Perspective
We’re looking to speak with 2 experts (one from a pharma company and one from a vendor) to begin with who have a good idea about outsourcing opportunities present within the heor (health economics and outcomes research) segment. This would be for a 1 - hour paid phone consult. Please respond with a few brief statements as to your relevance in this space. 1. Can you discuss the different services within the heor function and who are the key players in europe/us? 2. Would you be able to explain the spend by phase/activity/expected peak sales/company size a. For example: what is the spend on rwe/rwd analysis and htas by phase/peak sales of a given molecule 3. Can you share your insights on mega trends/tech disruption in the segment because of ai/ml a. How has the market evolved over the last 3 years and where is it headed in the coming 3 years? Companies: novartis, pfizer, jazz pharmaceuticals, allergan, amgen, celgene vendors: parexel, evidera, iqvia, drg, laser analytica note: we are looking to speak only with us/eu experts.
Jinender |Associate Director
I could provide an industry perspective on the above questions. I have more than 10 years of experie...9.3 Hours Later
I do not have expertise in this field ...9.3 Hours Later
Stephanie |Senior Director
I would be happy to talk to you about the direction that HEOR and *****ices are heading. I ha...10.5 Hours Later